跳至主要内容
临床试验/CTRI/2023/07/055508
CTRI/2023/07/055508尚未招募2/3 期

CLINICAL STUDY OF AAMRADI HIMA AND SHATAVARI TAILA MATRA BASTI ON ASRIGDARA

Post Graduate Institute of Ayurveda ,Jodhpur Rajasthan1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年1月8日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Assess improvement of sign & symptoms according to Pictorial blood loss assessment chart

研究概览

简要总结

This is a single group ,open label  clinical study  to evaluate the effect of Amradi hima and shatavari taila matra basti in the management of Asrigdara .To reduce the sign and symptoms assess from the pictorial blood loss assessment chart(Amount and Duration of bleeding),intermenstrual bleeding with or without pain  and improve the amount of  hemoglobin .Aamradi hima was sheet,vata -pitta shamak,rakta stambhak ,Daha prashmak in nature and shatavari roots are  phytoestrogens. menorrhagia is due to anexcess of estrogen or reduced estrogen (atrophy of endometrium) it can help in eithercase.The roots are considered as an astringent hence they reduce menstrual flowby this property. Moreover,Asparagus was found to bean effective antiulcerogenic and anti-secretory agentand thus has its role in healing of endometrium. Basti pacifying *vata,*restoring the disturbed Kapha and Pitta at their origin seats thus helpsin breaking pathogenesis. so we are choosing matra basti in the management of Asrigdara.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
14.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Excessive bleeding or prolonged bleeding (More than 7 days) or shortness of cycle (<21 days).
  • ⮚Excessive menstrual bleeding during menstruation (menstrual blood loss >80 ml in 1-7 days) having pictorial blood loss assessment chart (PBLAC) score more than 100 points for 2 consecutive cycles.
  • Along with or without Body ache (Angamarda) and Pain (Vedana) Women between the age group 14 to 50 years (married & unmarried).
  • After 3 months withdrawal of OC pills.

排除标准

  • Patients having bleeding due to abortion.
  • Bleeding from the site other than the uterus.
  • Patients with known Coagulation disorders.
  • Patients suffering from malignancies and chronic systemic diseases like, uncontrolled diabetes (above the range of 160-200 mg/dl), uncontrolled hypertension (Systolic blood pressure >180 & diastolic blood pressure >120mm hg).
  • Patients having Hepatitis, VDRL, HIV/AIDS.
  • If a patient conceives during trial.

结局指标

主要结局

Assess improvement of sign & symptoms according to Pictorial blood loss assessment chart

时间窗: 60 days

次要结局

  • Relief in associate symptoms like pain during menses,intermenstrual bleeding(60 days)

研究者

发起方
Post Graduate Institute of Ayurveda ,Jodhpur Rajasthan
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验